Most reports have indicated that T cells are restricted to self major histocompatibility complex (MHC) 1 determinants by radiation-resistant thymic epithelium (reviewed in 1 and 2), or by intrathymic bone marrow-derived cells (3-5). However, others (6-8) have presented evidence that this self-restriction is, at best, a relative phenomenon largely induced by peripheral priming. A major problem in the experimental analysis of this issue is the strong allo-response elicited by cross-haplotype stimulation. Three general methods have been used to remove alloreactive precursors prior to stimulation with non-MHC antigens in an H-2-different environment: (a) acute depletion of alloreactive cells by negative selection in vivo through allogeneic irradiated hosts, adsorption in vitro on allogeneic monolayers, or "suicide" of proliferating cells that have been stimulated with alloantigen; (b) construction of radiation and embryo-fusion chimeras; and (c) neonatal tolerance induction. The latter two approaches yield chronically tolerized cell populations.
TNP and minor histocompatibility antigens could be recognized in the context of the tolerated H-2 haplotype. Conversely, Waldmann et al. (21) and Zinkernagel et al. (22) were unable to demonstrate, respectively, allorestricted T-B help or anti-vaccinia CTL responses in mice made tolerant as neonates.
We have now analyzed the capacity of H-2 b mice neonatally tolerized to H-2K k to make an H-2Kk-restricted vaccinia response. These experiments are similar in design to those of Zinkernagel et al. (22) , the differences being that we used strain combinations which have been shown to be associated with aberrant recognition by adult negatively selected T cells, and have tested both thymus and spleen at much earlier time points than were previously examined. Neonatal Tolerance Induction. Newborn mice (_<24 h) were injected intravenously (i.v.) via the orbital branch of the anterior facial vein with 2-4 × 107 allogeneic or semiallogeneic cells suspended in 0.1 ml of Puck's medium or phosphate-buffered saline (PBS).
Alloreactive CTL. A standard protocol was used (23) . The culture medium was RPMI 1640 (Gibco Laboratories, Grand Island Biological Co., Grand Island, NY), supplemented with 10% fetal calf serum (FCS), 2 mercaptoethanol (5 × 10-5), penicillin (100 U/ml), streptomycin (100 mg/ml), gentamycin (0.1 mg/ml), minimal essential medium, nonessential amino acids, sodium pyruvate, and essential amino acids. Basically, 1.0-1.5 × 107 spleen cells were mixed with 2.0 X 10 7 irradiated (1,100 rad from a Cesium source) semiallogeneic or allogeneic stimulator cells, using 10.0 ml of medium in 25-cm 2 plastic tissue culture flasks. These cultures were incubated for 5-6 d at 37°C in 8% COz, and lymphocytes were then asayed for 4-6 h at o 51 k b d
37 C on Cr-labeled, uninfected L cells (H-2), MC57G (H-2), and KD2SV (H-2) or P815 (H-2 d) targets. The effector/target (E/T) ratio used was calculated from the number of cells present in the flask at the end of the 5-to 6-d culture period. At the end of incubation, a 100-/LI aliquot of supernatant was removed for counting in a Beckman Gamma 400 spectrometer (Beckman Instruments, Inc., Fullerton, CA). Groups were assayed in quadruplicate, and results are expressed as mean percent specific 51Cr-release relative to spontaneous release (SR) in media alone, or maximum release (MR) in cetramide saline alone, calculated as: ([percent experimental release -SR]/[MR -SR]) × 100. SR never exceeded 25% of MR, and standard errors of mean percent specific 51Cr-release were always <5%. Thymus cells used as responders were mixed at 2-3 × 107 cells with 2 × 107 irradiated stimulators and, in certain experiments, 1 × 107 irradiated (1,100 rad) spleen cells syngeneic with responder thymus and/or interleukin 2 (Collaborative Research Inc., Waltham, MA) at 5 half-U/ml were added on day 0 of culture.
Generation and Assay of Virus-specific CTL. Single-cell suspension of thymus and spleen (at least 2 × 107) were injected i.v. into mice lethally irradiated (850 tad) 24 h previously (24) . The recipients were then inoculated i.v. with 5 × 106 plaque-forming units of vaccinia virus after 3 h, and spleen cells from these mice were assayed for CTL activity 6 d later. The virusinfected (VACC) and uninfected (N) target ceils used were: L cells (H-2KkDk), MC57G (H2KbDb), and KD2SV (H-2KdDa). The assays were incubated for 7-8 h at 37°C, and results are expressed as specific 51Cr release.
Reagents. Monoclonal anti-Thy-1.2 (Jlj) IgM antibody was made as previously reported (25) and used at a 1:40 dilution of ascites fluid in a one-step protocol with 1:25 dilution of guinea pig complement (Flow Laboratories, Inc., Rockville, MD) in 7% COz at 37°C. k Anti-H-2 antiserum was raised in (CB6)F1 mice primed with C3H spleen cells and used at 1:I0 dilution in a two-step protocol: 5 X 107 cells/ml were mixed with antibody on ice for 30 min, washed, and incubated for 30 min at 5 × 10 7 cells/ml with guinea pig complement (1:5 dilution) plus rabbit complement (1:60). Treatments were carried out in RPMI 1640 plus 10% FCS, and cells were washed twice with RPMI before culture or with PBS bfore i.v. injection.
Results
Normal B6 spleen and thymus cells recovered 6 d after transfer into irradiated, infected (k × b)Fa hosts often do not kill normal H-2 k targets, even though they are clearly capable of generating an anti-H-2 k CTL response when simultaneously stimulated in vitro (data not shown). Thus, it is possible that an ongoing allo-response could suppress a virus-specific T cell response restricted to that foreign haplotype in vivo, even if the anti-allo CTL were undetectable in the spleen at time of assay. Therefore, only neonatally tolerized animals whose cells did not generate an anti-H-2 k CTL response in vitro were considered tolerant. We have shown elsewhere that this tolerance is due to a central deletion of alloreactive CTL-P rather than positive suppression or absence of help. 2 Typical data for in vitro CTL allo-responsiveness are presented in Table I . The same animals were used for the experiment presented in Table II , which shows that spleen cells, but not thymocytes, from 24-d-old B6 mice neonatally tolerized with untreated (B6C3)FI spleen cells made a significant response to H-2 k + vaecinia when transferred into irradiated infected C3H hosts. However, when spleen cells from these mice were pretreated with anti-H-2 k + complement(C') before transfer, they no longer generated H-2K-restricted virus-specific CTL, whereas the response to H-2 b + vaccinia was retained. The cells that responded to H-2 k + virus must, therefore, have originated from the inoculum used to induce tolerance. Maintenance of neonatally induced tolerance requires low level chimerism (26) , generally estimated to be <10% (27, 28) . Nossal and Pike (29) used fluoresceinated inocula to demonstrate 0.1% donor cells in thymus and 4% in spleen 24 h after injection. Our own estimates for chimerism in spleens at various ages range from 0 to 20% using pooled antisera in a standard twostep protocol, z Hence, to avoid the possibility that even a small number of (k × b)F1 T cells may be sufficiently expanded in the adoptive host to give a detectable virus-specific H-2 krestricted response, a second approach used anti-Thy-1-treated F1 cells as the tolerizing inoculum. The kinetics of vaccinia-specific T lymphocyte reconstitution of lethally irradiated mice by cells of donor origin has been reported by us previously (18) (Table III) . By day 31 post-injection of these anti-Thy + C'-treated Fa cells, a 1,000-rad irradiated B6 host begins to show a T cell response to vaccinia (group G, Table  III ), but cells from neonatally tolerized 25-or 35-d-old mice still do not show allorestricted killing 6 d after transfer to infected hosts (groups F, H, and I, Table III) .
In an effort to uncover possible synergistic interactions between spleen and thymus cells of neonatally tolerized mice, we injected mixtures of splenocytes and thymocytes 2 Schwartz, D. H., and P. C. Doherty. Mechanisms of tolerance in mice exposed to alloantigens as neonates. Manusc~'ipt submitted for publication. 
* Pooled cells from three animals were stimulated in vitro for 6 d.
:~ The specific lysis on syngeneic MC57 targets was _<4% for all groups. The E/T ratio is calculated for numbers of cells present at the end of the 6-d culture period. 
tolerized mice were adoptively transferred into irradiated recipients, with * Lymphocytes from neonatally k or without treatment with anti-tl-2K + C', and stimulated with vaccinia virus for 6 d. :~ Not done, from tolerized animals (as judged by absence of alloreactive cell-mediated lympholysis in vitro) into irradiated (B6C3)F1 hosts. Again, we found significant virus-specific killing in the context of the syngeneic, but not the tolerated, H-2 haplotype (Table   IV) .
The H-2D k allele is invariably associated with CTL nonresponsiveness to vaccinia virus (1). Thus any "aberrant" recognition by B6 T cells stimulated in a k-or (k X b)Frstimulating environment would presumably be restricted to K k, just as in the acute negative selection experiments where KkD b recombinants were used as irradiated filter and stimulator hosts (14, 17) . However, in light of the explanation originally put forth for the aberrant recognition phenomenon (14) , namely that H-2K k + vaccinia "looked like" H-2 b + X, it seemed possible that tolerance to H-2D k alloantigens and/ or C3H minor histocompatibility antigens could eliminate a significant portion of the H-2K k + vaccinia reactive clones. We therefore considered it important to use a 
TABL~ V

Absence of K k + Vaccinia Response by B6 Cells Tolerant of Recombinant or Fully Allogeneic H-2
H-J).
Discussion
The capacity of allotolerant CTL populations from H-2 b mice to respond to vaccinia-infected H-2 k cells varies among different experimental protocols. At one end of the spectrum, it seems that acutely depleted negatively selected adult H-2 b cells make at least as strong a response to H-2K k + vaccinia as to H-2 b + vaccinia (14, 17) . At the other, H-2 b animals made tolerant at birth to H-2 k are unable to generate CTL-specific for H-2 k + vaccinia. The intermediate situation is found with (k × b) ---~b chimeras, where H-2b-restriction of thymocytes seems to hold, but spleen cells of older (several months) animals exhibit variable responsiveness to vaccinia in the context of H-2 k (18). Analysis of the similarities and differences among these protocols may reveal clues to explain the apparent discrepancies.
We have demonstrated elsewhere that our neonatally tolerized B6 animals are functionally depleted of anti-H-2 k CTL-P and are not actively suppressed in vitro. which shows that H-2 b thymic epithelium is the single common feature of all three experimental systems. It is at least arguable that central elimination of high affinity anti-self MHC clones occurs before encounter with the thymic epithelium, whereas low affinity anti-self clones proliferate intrathymically before leaving and alloreactive clones with no crossreactivity for self (if such cells exist as a separate set) may simply pass through the thymus. We further suggest that the majority of anti-K k + vaccinia CTL-P in a normal B6 animal are derived by somatic mutation and expansion from anti-H-2K k progenitor clones, whereas relatively few are derived from low-affinity anti-H-2 b (anti-"altered self") clones having no cross-affinity for H-2 k. Acute depletion (negative selection) of high-affinity anti-H-2 k CTL-P from the adult B6 repertoire does not remove all of the anti-H-2 k + vaccinia reactive clones, as the latter have only low affinity for H-2 k. Theoretically, reactivity for any allo-MHC + antigen X is permissible but not necessarily present or predictable in any T cell population that is operationally restricted to a particular MHC type.
In contrast, neonatally tolerized animals have had a central deletion of both the high-affinity anti-H-2 b clones, and the anti-H-2 k clones. The latter are therefore unavailable for somatic mutation and expansion in the thymus or periphery to give rise to anti-K k + vaccinia CTL-P. Low numbers of anti-H-2K k + vaccinia clones in neonatally tolerized mice might be revealed by limiting dilution or in vitro restimulation but are not numerous enough to cause observable lysis in bulk assays of cells from in vivo primed mice.
The (k × b) ~ b chimera is similar to the neonatally tolerized animal in that, again, there has been a central deletion of high affinity anti-H-2 k and H-2 b clones. The clones potentially available for H-2K k + vaccinia recognition are low-affinity anti-H-2 b clones and perhaps, as discussed below, low-affinity anti-H-2 k clones. The thymi and spleens of young chimeras would thus contain few anti-H-2K k + vaccinia CTL-P. However, unlike the situation for normal or neonatally tolerized H-2 b animals, the presenting accessory cell population in the peripheral lymphoid tissue of the Fa ~ P chimeras is H-2 k x b This could provide stimulation by H-2 k + X antigens, which cross-stimulate for K k -I-vaccinia, and over time, the peripheral pool of aberrantly reactive CTL-P would increase. The prediction would be that the anti-K k + vaccinia CTL from spleens of older (k × b) --~ b chimeras would express idiotypes different from those of anti-K k + vaccinia CTL present in normal negatively selected spleen populations.
One of us has previously suggested (30) that low-as well as high-affinity anti-H-2 k clones would be eliminated intrathymically if they encountered H-2 k on nonepithelial elements, i.e., other thymocytes. This idea was put forward to account for the lack of aberrant recognition seen in (k × b) ~ b chimeras tested up to that time. Subsequent findings (31) of anti-H-2 k + vaccinia reactivity in adoptively transferred spleens of some older (k × b)---~b chimeras is accommodated by postulating that these crossreactive clones can be derived via somatic mutation from low-affinity anti-H-2 b progenitors. To account for the data from neonatally tolerized mice, we would have to argue that the very low level of H-2 k chimerism in these animals is sufficient to delete low affinity anti-H-2 k clones capable of responding to H-2K k + vaccinia. This places even more emphasis on the premise of extreme sensitivity on the part of these low affinity clones to intrathymic, but not pre-or post-thymic, deletion (an idea originally invoked to explain the ability of K k + vaccinia restricted clones to escape negative selection in allogeneic hosts).
An alternative explanation for the absence of H-2k-restricted vaccinia-specific CTL-P in neonatally tolerized mice is that high-rather than low-affinity anti-H-2 k progenitor clones comprise the major source of H-2K k + vaccinia reactive progeny (either by virtue of originally greater frequencies or selective somatic mutation and expansion). Elimination of these high-affinity clones by long-term contact with very low levels of H-2 k antigen would give the neonatally tolerized animal a nonresponder phenotype to H-2K k + vaccinia, even with persistence of low affinity anti-H-2 k clones.
Considerable experimental evidence from other laboratories is in accord with our results. Wagner et al. (6) found allorestricted anti-Sendai and anti-TNP CTL-P in mice of several strains when tested in vitro with limiting dilution assays after removal of alloreactive cells on monolayers. There was a numerical bias towards self-restricted vs. allorestricted CTL-P (3-10:1) present in both spleen and thymus cells of normal animals. These authors also present evidence that this central thymic bias for selfrestriction is a function of syngeneic interactions between CTL-P and bone-marrowderived elements in the thymus. The radiation-resistant thymic epithelium seems not to influence this self-preference, as completely allogeneic thymus-stem cell chimeras revealed the same skewing of restriction to stem-cell MHC. They argue persuasively for the idea, originally formulated by Finberg et al. (32) that Ly-2,3 + CTL-P in the periphery are really derived from Ly-1,2,3 ÷ self-restricted precursors (33, 34) . This idea is supported by the age-related increase in frequencies of alloreactive and Sendalspecific allorestricted CTL-P found in spleen. No such increase was observed in the thymus. Kruisbeek et al. (7) found that in allogeneic thymus-engrafted nude mice it is the thymic epithelium rather than host-derived elements which determines selfrestriction of thymocytes. This would appear to conflict with the finding of Wagner et al. (6) . However, spleen cells from thymus-grafted nudes were restricted to host as well as to thymus haplotype, an observation that is in agreement with the concept of peripherally imposed self-restriction.
Experiments recently reported by Mullbacher (35) showed that neonatally induced tolerance to H-2 b eliminated the ability of adult CBA (H-2 k) mice to make an H-2 krestricted anti-H-Y response. This was true for 100% of neonatally tolerized animals, even though the anti-H-Y response is crossreactive with H-2 b in only 10-20% of normal adult CBA mice. Mullbacher (36) favors a peripheral anti-idiotype suppression model which he has previously detailed. However, the analogies to our present findings are striking, and it seems likely that for H-2 k + H-Y (which is actually limited to H-2D k + H-Y) as for H-2K k + vaccinia, chronic central elimination of a progenitor (germ line?) repertoire eliminates potentially reactive daughter clones. Fig. 1 illustrates how our model could account for our data and Mullbacher's (35).
Summary
Thymocytes and spleen cells from C57BL/6 mice (H-2 b) neonatally tolerized to H-2 k alloantigens do not generate an anti-vaccinia response restricted to H-2K u when adoptively transferred to appropriate irradiated hosts. This is in sharp contrast to the case for negatively selected C57BL/6 spleen cells acutely depleted of alloreactivity. No evidence for suppression was found in cell mixture experiments.
We have shown elsewhere that our neonatally tolerized animals have a centrally induced deletion-type tolerance in the absence of obvious suppression. 2 We now suggest that in the neonatally tolerized mouse, chronic, central deletion of anti-H-2 k clones during early T cell ontogeny eliminates the major source of cells able to give rise, via somatic mutation and expansion, to anti-H-2K k + vaccinia specific cytotoxic T lymphocyte precursors (CTL-P) in the adult. A similar mechanism may operate in the (k X b) ~ b chimera; however, the presence of H-2 k x b accessory and presenting cells may permit the eventual generation (via cross-stimulation) of an H-2k-restricted vaccinia-specific repertoire. This would account for our observation of such "aberrant recognition" CTL-P emerging in the spleens of older (k X b) ~ b chimeras.
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